Skip to main content Accessibility help
×
Home
Hostname: page-component-ffbbcc459-gmk6f Total loading time: 0.381 Render date: 2022-03-14T18:30:09.878Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true }

Structural brain changes associated with tardive dyskinesia in schizophrenia

Published online by Cambridge University Press:  02 January 2018

Salvador Sarró
Affiliation:
FIDMAG Germanes Hospitalàries, Barcelona, CIBERSAM and Psychiatry and Clinical Psychology programme, Universitat Autònoma de Barcelona, Barcelona, Spain
Edith Pomarol-Clotet
Affiliation:
FIDMAG Germanes Hospitalàries, Barcelona and CIBERSAM, Spain
Erick J. Canales-Rodríguez
Affiliation:
FIDMAG Germanes Hospitalàries, Barcelona and CIBERSAM, Spain
Raymond Salvador
Affiliation:
FIDMAG Germanes Hospitalàries, Barcelona and CIBERSAM, Spain
Jesús J. Gomar
Affiliation:
Germanes Hospitalàries, Barcelona, CIBERSAM, Spain, and The Litwin-Zucker Research Center, the Feinstein Institute for Medical Research, Manhasset, New York, USA
Jordi Ortiz-Gil
Affiliation:
Germanes Hospitalàries, Barcelona, CIBERSAM and Hospital General de Granollers, Barcelona, Spain
Ramón Landín-Romero
Affiliation:
Germanes Hospitalaries, Barcelona and CIBERSAM, Spain
Fidel Vila-Rodríguez
Affiliation:
Department of Psychiatry, University of British Columbia, Vancouver, Canada, and Fundació Sant Joan de Déu, Barcelona, Spain
Josep Blanch
Affiliation:
Fundació Sant Joan de Déu, Barcelona, Spain
Peter J. McKenna*
Affiliation:
Germanes Hospitalàries, Barcelona and CIBERSAM, Spain
*
Peter McKenna, FIDMAG Germanes Hospitalaries, C./Dr Antoni Pujadas 38, 08830 – Sant Boi de Llobregat, Barcelona, Spain. Email: pmckenna@fidmag.com
Rights & Permissions[Opens in a new window]

Abstract

HTML view is not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background

The pathological basis of tardive dyskinesia is unknown. Although its clinical features implicate the basal ganglia, imaging studies have not found clear evidence that it is associated with volume changes in these or other brain structures.

Aims

To determine, using voxel-based structural imaging, whether there are regions of grey matter volume change in people with schizophrenia who also have tardive dyskinesia compared with those without tardive dyskinesia.

Method

A total of 81 people with chronic schizophrenia, 32 with tardive dyskinesia and 49 without, were examined using magnetic resonance imaging (MRI) and whole-brain, optimised voxel-based morphometry. A comparison group of 61 healthy controls was also examined.

Results

Compared with those without tardive dyskinesia, patients with tardive dyskinesia showed a pattern of volume reductions in predominantly subcortical regions, including the basal ganglia and the thalamus. Within the basal ganglia, volume reductions were seen in the caudate nucleus, to a lesser extent in the putamen, and only marginally in the globus pallidus. The patients with tardive dyskinesia, but not those without, showed significant volume reductions in the basal ganglia compared with the healthy controls but both groups had smaller volumes than controls in other affected areas.

Conclusions

The pathological process or processes that underlie the development of tardive dyskinesia are not just neurochemical in nature, but affect brain structure.

Type
Papers
Copyright
Copyright © Royal College of Psychiatrists, 2013 

Footnotes

See editorial, pp. 6–7, this issue.

Declaration of interest

None.

References

1 Cunningham Owens, DG. A Guide to the Extrapyramidal Side-Effects of Neuroleptic Drugs. Cambridge University Press, 1999.CrossRefGoogle Scholar
2 Fenton, WS. Prevalence of spontaneous dyskinesia in schizophrenia. J Clin Psychiatry 2000; 61 (suppl 4): 10–4.Google Scholar
3 Owens, DG, Johnstone, EC, Frith, CD. Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics. Arch Gen Psychiatry 1982; 39: 452–61.CrossRefGoogle ScholarPubMed
4 McCreadie, RG, Thara, R, Kamath, S, Padmavathy, R, Latha, S, Mathrubootham, N, et al Abnormal movements in never-medicated Indian patients with schizophrenia. Br J Psychiatry 1996; 168: 221–6.CrossRefGoogle ScholarPubMed
5 Whitty, PF, Owoeye, O, Waddington, JL. Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology. Schizophr Bull 2009; 35: 415–24.CrossRefGoogle ScholarPubMed
6 Crow, TJ, Owens, DG, Johnstone, EC, Cross, AJ, Owen, F. Does tardive dyskinesia exist? Mod Probl Pharmacopsychiatry 1983; 21: 206–19.CrossRefGoogle ScholarPubMed
7 Casey, DE. Tardive dyskinesia: pathophysiology and animal models. J Clin Psychiatry 2000; 61 (suppl 4): 59.Google ScholarPubMed
8 Klawans, HL, Weiner, WJ. The pharmacology of choreatic movement disorders. Prog Neurobiol 1976; 6: 4980.CrossRefGoogle ScholarPubMed
9 Gerlach, J. Tardive dyskinesia. Dan Med Bull 1979; 26: 209–45.Google ScholarPubMed
10 Mackay, AV, Iversen, LL, Rossor, M, Spokes, E, Bird, E, Arregui, A, et al Increased brain dopamine and dopamine receptors in schizophrenia. Arch Gen Psychiatry 1982; 39: 991–7.CrossRefGoogle Scholar
11 Cross, AJ, Crow, TJ, Ferrier, IN, Johnson, JA, Johnstone, EC, Owen, F, et al Chemical and structural changes in the brain in patients with movement disorder. Psychopharmacology Suppl 1985; 2: 104–10.CrossRefGoogle ScholarPubMed
12 Kornhuber, J, Riederer, P, Reynolds, GP, Beckmann, H, Jellinger, K, Gabriel, E. 3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms. J Neural Transm 1989; 75: 110.CrossRefGoogle ScholarPubMed
13 Adler, CM, Malhotra, AK, Elman, I, Pickar, D, Breier, A. Amphetamine-induced dopamine release and post-synaptic specific binding in patients with mild tardive dyskinesia. Neuropsychopharmacology 2002; 26: 295300.CrossRefGoogle ScholarPubMed
14 Owens, DG, Johnstone, EC, Crow, TJ, Frith, CD, Jagoe, JR, Kreel, L. Lateral ventricular size in schizophrenia: relationship to the disease process and its clinical manifestations. Psychol Med 1985; 15: 2741.CrossRefGoogle ScholarPubMed
15 Hoffman, WF, Casey, DE. Computed tomographic evaluation of patients with tardive dyskinesia. Schizophr Res 1991; 5: 112.CrossRefGoogle ScholarPubMed
16 Mion, CC, Andreasen, NC, Arndt, S, Swayze, VW 2nd, Cohen, GA. MRI abnormalities in tardive dyskinesia. Psychiatry Res 1991; 40: 157–66.CrossRefGoogle ScholarPubMed
17 Elkashef, AM, Buchanan, RW, Gellad, F, Munson, RC, Breier, A. Basal ganglia pathology in schizophrenia and tardive dyskinesia: an MRI quantitative study. Am J Psychiatry 1994; 151: 752–5.Google ScholarPubMed
18 Waddington, JL, O'Callaghan, E, Buckley, P, Madigan, C, Redmond, O, Stack, JP, et al Tardive dyskinesia in schizophrenia. Relationship to minor physical anomalies, frontal lobe dysfunction and cerebral structure on magnetic resonance imaging. Br J Psychiatry 1995; 167: 41–4.CrossRefGoogle ScholarPubMed
19 Wright, IC, Rabe-Hesketh, S, Woodruff, PW, David, AS, Murray, RM, Bullmore, ET. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 2000; 157: 1625.CrossRefGoogle Scholar
20 Brandt, GN, Bonelli, RM. Structural neuroimaging of the basal ganglia in schizophrenic patients: a review. Wien Med Wochenschr 2008; 158: 8490.CrossRefGoogle ScholarPubMed
21 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994.Google Scholar
22 Simpson, GM, Lee, JH, Zoubok, B, Gardos, G. A rating scale for tardive dyskinesia. Psychopharmacology (Berl) 1979; 64: 171–9.CrossRefGoogle ScholarPubMed
23 Schooler, NR, Kane, JM. Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 1982; 39: 486–7.Google ScholarPubMed
24 Peralta, V, Cuesta, MJ. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia. Psychiatry Res 1994; 53: 3140.CrossRefGoogle Scholar
25 Del Ser, T, Gonzalez-Montalvo, JI, Martinez-Espinosa, S, Delgado-Villapalos, C, Bermejo, F. Estimation of premorbid intelligence in Spanish people with the Word Accentuation Test and its application to the diagnosis of dementia. Brain Cogn 1997; 33: 343–56.CrossRefGoogle ScholarPubMed
26 Wechsler, D. Wechsler Adult Intelligence Scale (3rd edn). The Psychological Corporation, 1997.Google Scholar
27 Good, CD, Johnsrude, IS, Ashburner, J, Henson, RN, Friston, KJ, Frackowiak, RS. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001; 14: 2136.CrossRefGoogle ScholarPubMed
28 Smith, SM, Jenkinson, M, Woolrich, MW, Beckmann, CF, Behrens, TE, Johansen-Berg, H, et al Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004; 23 (suppl 1): S20819.CrossRefGoogle ScholarPubMed
29 Smith, SM. Fast robust automated brain extraction. Hum Brain Mapp 2002; 17: 143–55.CrossRefGoogle ScholarPubMed
30 Bartels, M, Themelis, J. Computerized tomography in tardive dyskinesia. Evidence of structural abnormalities in the basal ganglia system. Arch Psychiatr Nervenkr 1983; 233: 371–9.CrossRefGoogle ScholarPubMed
31 Bai, YM, Chou, KH, Lin, CP, Chen, IY, Li, CT, Yang, KC, et al White matter abnormalities in schizophrenia patients with tardive dyskinesia: a diffusion tensor image study. Schizophr Res 2009; 109: 167–81.CrossRefGoogle ScholarPubMed
32 Alexander, GE, DeLong, MR, Strick, PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9: 357–81.CrossRefGoogle ScholarPubMed
33 Parent, A, Hazrati, LN. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev 1995; 20: 91127.CrossRefGoogle ScholarPubMed
34 Cummings, JL. Anatomic and behavioral aspects of frontal-subcortical circuits. Ann N Y Acad Sci 1995; 769: 113.CrossRefGoogle ScholarPubMed
35 Quinn, N, Schrag, A. Huntington's disease and other choreas. J Neurol 1998; 245: 709–16.CrossRefGoogle ScholarPubMed
36 Chua, SE, Cheung, C, Cheung, V, Tsang, JT, Chen, EY, Wong, JC, et al Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia. Schizophr Res 2007; 89: 1221.CrossRefGoogle ScholarPubMed
37 Leung, M, Cheung, C, Yu, K, Yip, B, Sham, P, Li, Q, et al Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting. Schizophr Bull 2011; 37: 199211.CrossRefGoogle ScholarPubMed
38 McCreadie, RG, Thara, R, Padmavati, R, Srinivasan, TN, Jaipurkar, SD. Structural brain differences between never-treated patients with schizophrenia, with and without dyskinesia, and normal control subjects: a magnetic resonance imaging study. Arch Gen Psychiatry 2002; 59: 332–6.CrossRefGoogle ScholarPubMed
39 Mittal, VA, Daley, M, Shiode, MF, Bearden, CE, O'Neill, J, Cannon, TD. Striatal volumes and dyskinetic movements in youth at high-risk for psychosis. Schizophr Res 2010; 123: 6870.CrossRefGoogle ScholarPubMed
40 Bjorklund, A, Dunnett, SB. Dopamine neuron systems in the brain: an update. Trends Neurosci 2007; 30: 194202.CrossRefGoogle ScholarPubMed
41 Dorph-Petersen, KA, Pierri, JN, Perel, JM, Sun, Z, Sampson, AR, Lewis, DA. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 2005; 30: 1649–61.CrossRefGoogle ScholarPubMed
42 Ho, BC, Andreasen, NC, Ziebell, S, Pierson, R, Magnotta, V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry 2011; 68: 128–37.CrossRefGoogle ScholarPubMed
Supplementary material: PDF

Sarró et al. supplementary material

Supplementary Material

Download Sarró et al. supplementary material(PDF)
PDF 207 KB
Submit a response

eLetters

No eLetters have been published for this article.
You have Access
25
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Structural brain changes associated with tardive dyskinesia in schizophrenia
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Structural brain changes associated with tardive dyskinesia in schizophrenia
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Structural brain changes associated with tardive dyskinesia in schizophrenia
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *